{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:10:28Z","timestamp":1771827028410,"version":"3.50.1"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The coexistence of tuberculosis (TB) and type 2 diabetes mellitus (T2DM) represents a growing global health challenge, particularly in low- and middle-income countries where TB remains endemic and T2DM prevalence is rising. Patients with T2DM exhibit a threefold higher risk of developing active TB and frequently present with more severe disease, including increased bacillary burden, delayed culture conversion, and higher relapse rates. These outcomes reflect the complex immunometabolic interactions between the two conditions. MicroRNAs (miRNAs), small non-coding regulators of post-transcriptional gene expression, emerge as potential biomarkers capable of integrating immune and metabolic processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>we conducted a systematic review of studies published between 2011 and 2025 in PubMed and Google Scholar, following PRISMA 2020 guidelines. Only studies involving adult human samples were included. Dysregulated miRNAs were standardized using miRBase and analyzed with miRNet v2.0, miRTarBase v9.0, and DIANA-miRPath v3.0. Interaction networks were constructed in Cytoscape, and functional enrichment analyses were performed using ClusterProfiler and MSigDB to identify shared pathways and gene targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis revealed a set of miRNAs altered in both TB and T2DM, including hsa-miR-21, hsa-miR-29a-3p, hsa-miR-125a-5p, hsa-miR-125b, hsa-miR-130b, hsa-miR-144, hsa-miR-155, hsa-miR-223, and hsa-miR-486. These miRNAs converge on central target genes such as STAT3, PTEN, BCL2, MYC, RAF1, EGFR, IRS1, SMAD4, FOXO3, GLUT4, AKT1, and CTNNB1, regulating pathways of insulin signaling, glucose metabolism, apoptosis, inflammation, and fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Shared miRNAs act as molecular nodes linking immunity and metabolism, providing a framework for biomarker development in TB-T2DM comorbidity. Their regulatory convergence suggests potential applications in diagnosis, prognosis, and therapeutic innovation, particularly in vulnerable populations where both diseases intersect. These findings underscore the importance of integrating immunometabolic biomarkers into personalized medicine strategies to address the dual burden of TB and T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1760933","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:27:42Z","timestamp":1771824462000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 diabetes mellitus associated microRNAs in tuberculosis susceptibility: a systematic review and bioinformatic analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Rodolfo L.","family":"Ch\u00e1vez-Dom\u00ednguez","sequence":"first","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Viettri","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Torres","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzel A.","family":"Corona-Galvan","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Hern\u00e1ndez-Diego","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Casta\u00f1\u00f3n-Arreola","sequence":"additional","affiliation":[{"name":"Posgrado en Ciencias Gen\u00f3micas, Universidad Aut\u00f3noma de la Ciudad de M\u00e9xico","place":["Ciudad de M\u00e9xico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Carranza","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunobiolog\u00eda de la Tuberculosis, Instituto Nacional de Enfermedades, Respiratorias Ismael Cos\u00edo Villegas","place":["Ciudad de Mexico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"B1","first-page":"1","volume-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"B2","first-page":"1","volume-title":"IDF diabetes atlas. 10th edition","author":"Magliano","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: A systematic review","volume":"9","author":"Baker","year":"2011","journal-title":"BMC Med"},{"key":"B4","article-title":"Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PloS Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0023-2016","article-title":"Diabetes and tuberculosis","volume":"4","author":"Restrepo","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.86","article-title":"Circulating microRNAs as novel biomarkers for diabetes mellitus","volume":"9","author":"Guay","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C112.439778","article-title":"Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity","volume":"288","author":"Singh","year":"2013","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05459-11","article-title":"Circulating microRNAs in patients with active pulmonary tuberculosis","volume":"49","author":"Fu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.03.006","article-title":"Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy","volume":"77","author":"Barry","year":"2018","journal-title":"J Infection"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2015.0090","article-title":"MicroRNA-223 is upregulated in active tuberculosis patients and inhibits apoptosis of macrophages by targeting FOXO3","volume":"19","author":"Xi","year":"2015","journal-title":"Genet Testing Mol Biomarkers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/microorganisms11030626","article-title":"MicroRNAs as biomarkers of active pulmonary TB course","volume":"11","author":"Shepelkova","year":"2023","journal-title":"Microorganisms"},{"key":"B13","article-title":"MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus","volume":"6","author":"Karolina","year":"2011","journal-title":"Navarro A editor. PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.05.017","article-title":"Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals","volume":"463","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"44986","DOI":"10.1038\/srep44986","article-title":"Elevated miR-130a\/miR130b\/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell","volume":"7","author":"Ofori","year":"2017","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/ijms26020637","article-title":"Characterizing circulating microRNA signatures of type 2 diabetes subtypes","volume":"26","author":"Sulaiman","year":"2025","journal-title":"IJMS"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/cid\/ciaa751","article-title":"Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis","volume":"72","author":"Eckold","year":"2021","journal-title":"Clin Infect Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025832","article-title":"Comparative miRNA expression profiles in individuals with latent and active tuberculosis","volume":"6","author":"Wang","year":"2011","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00221514","article-title":"A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis","volume":"45","author":"Latorre","year":"2015","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126018","article-title":"Differential microRNA expression in human macrophages with mycobacterium tuberculosis infection of beijing\/W and non-beijing\/W strain types","volume":"10","author":"Zheng","year":"2015","journal-title":"PloS One"},{"key":"B21","article-title":"MicroRNA-365 in macrophages regulates Mycobacterium tuberculosis-induced active pulmonary tuberculosis via interleukin-6","volume":"8","author":"Song","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078381","article-title":"miR-582-5p is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO1","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"103563","DOI":"10.1016\/j.micpath.2019.103563","article-title":"Integrated bioinformatics analysis and validation revealed potential immune-regulatory miR-892b, miR-199b-5p and miR-582\u20135p as diagnostic biomarkers in active tuberculosis","volume":"134","author":"Zhang","year":"2019","journal-title":"Microbial Pathogenesis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1907426","article-title":"Serum exosomal miRNAs are associated with active pulmonary tuberculosis","volume":"2019","author":"Alipoor","year":"2019","journal-title":"Dis Markers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tube.2019.04.002","article-title":"Host and MTB genome encoded miRNA markers for diagnosis of tuberculosis","volume":"116","author":"Chakrabarty","year":"2019","journal-title":"Tuberculosis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2023.07.001","article-title":"microRNA hsa-miR-425-5p and hsa-miR-4523 expressions as biomarkers of active pulmonary tuberculosis, latent tuberculosis infection, and lymph node tuberculosis","volume":"8","author":"Massi","year":"2023","journal-title":"Non-coding RNA Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2527949","DOI":"10.1080\/07853890.2025.2527949","article-title":"Evaluating the expression level of serum Interleukin-2, lipoarabinomannan and circulating MicroRNA-29a as diagnostic biomarkers for pulmonary and extra-pulmonary tuberculosis: a pilot study","volume":"57","author":"Adhikary","year":"2025","journal-title":"Ann Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/ftubr.2024.1441258","article-title":"Serum-derived host miR-423-5p and miR-378a-3p as molecular markers for severe tuberculosis: a promising prognostic tool for survival","volume":"2","author":"Hurtado","year":"2024","journal-title":"Front Tuberc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.18.1.40","article-title":"Candidate blood microRNAs as potential biomarkers in patients with active and latent pulmonary tuberculosis infection","volume":"18","author":"El-Masry","year":"2024","journal-title":"J Pure Appl Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/diagnostics12020369","article-title":"Identification of microRNAs as potential blood-based biomarkers for diagnosis and therapeutic monitoring of active tuberculosis","volume":"12","author":"Kim","year":"2022","journal-title":"Diagnostics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/mmr.2021.11888","article-title":"Diagnostic value of microRNA\u2212125b in peripheral blood mononuclear cells for pulmonary tuberculosis","volume":"23","author":"Sun","year":"2021","journal-title":"Mol Med Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tube.2018.12.001","article-title":"MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis","volume":"114","author":"Ndzi","year":"2019","journal-title":"Tuberculosis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2017.03.007","article-title":"Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course","volume":"105","author":"Corral-Fern\u00e1ndez","year":"2017","journal-title":"Tuberculosis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tube.2017.08.010","article-title":"Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis","volume":"108","author":"Wang","year":"2018","journal-title":"Tuberculosis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184113","article-title":"Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals","volume":"12","author":"Cui","year":"2017","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.13805","article-title":"A group of novel serum diagnostic biomarkers for multidrug-resistant tuberculosis by iTRAQ-2D LC-MS\/MS and solexa sequencing","volume":"12","author":"Wang","year":"2016","journal-title":"Int J Biol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760468","article-title":"A Dual Marker for Monitoring MDR-TB Treatment: Host-Derived miRNAs and M. tuberculosis-Derived RNA Sequences in Serum","volume":"12","author":"Carranza","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2022.105325","article-title":"Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in Mycobacterium tuberculosis-infected macrophages by targeting miR-140-5p expression","volume":"103","author":"Sun","year":"2022","journal-title":"Infection Genet Evolution"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2020.1838792","article-title":"Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2)","volume":"19","author":"Liu","year":"2020","journal-title":"Cell Cycle"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2019.1590129","article-title":"Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion","volume":"8","author":"Tu","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70567","article-title":"miRNA differential expression profile analysis and identification of potential key genes in active tuberculosis","volume":"29","author":"Yang","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"127943","DOI":"10.1016\/j.micres.2024.127943","article-title":"Transport of miR-766\u20133p to A549 cells by plasma-derived exosomes and its effect on intracellular survival of Mycobacterium tuberculosis by regulating NRAMP1 expression in A549 cells","volume":"290","author":"Cui","year":"2025","journal-title":"Microbiological Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S412116","article-title":"Novel biomarker panel of let-7d-5p and miR-140-5p can distinguish latent tuberculosis infection from active tuberculosis patients","volume":"16","author":"Liu","year":"2023","journal-title":"IDR"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197805","article-title":"Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis","volume":"14","author":"Sampath","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088909","article-title":"Identification of serum microRNA biomarkers for tuberculosis using RNA-seq","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.08.008","article-title":"Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response","volume":"53","author":"Spinelli","year":"2013","journal-title":"Mol Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.11.016","article-title":"Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets","volume":"19","author":"Kameswaran","year":"2014","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.3390\/ijms25137078","article-title":"Analysis of circulating miRNA expression profiles in type 2 diabetes patients with diabetic foot complications","volume":"25","author":"Fuentevilla-Alvarez","year":"2024","journal-title":"IJMS"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0470","article-title":"Circulating exosomal miR-20b-5p is elevated in type 2 diabetes and could impair insulin action in human skeletal muscle","volume":"68","author":"Katayama","year":"2019","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1970","article-title":"Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy","volume":"71","author":"Shaker","year":"2019","journal-title":"IUBMB Life"},{"key":"B51","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/diagnostics11060949","article-title":"MicroRNAs-1299, -126-3p and -30e-3p as potential diagnostic biomarkers for prediabetes","volume":"11","author":"Weale","year":"2021","journal-title":"Diagnostics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx367","article-title":"Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes","volume":"33","author":"Roux","year":"2018","journal-title":"Nephrol Dialysis Transplantation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"bvae114","DOI":"10.1210\/jendso\/bvae114","article-title":"Dysregulated urinary extracellular vesicle small RNAs in diabetic nephropathy: implications for diagnosis and therapy","volume":"8","author":"Ali","year":"2024","journal-title":"J Endocrine Soc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00528","article-title":"MicroRNA-1281 as a novel circulating biomarker in patients with diabetic retinopathy","volume":"11","author":"Greco","year":"2020","journal-title":"Front Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abst.2023.05.001","article-title":"Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases","volume":"5","author":"Raza","year":"2023","journal-title":"Adv biomark Sci Technology"},{"key":"B56","article-title":"Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155","volume":"19","author":"Yang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9214","article-title":"Diagnostic value of VDBP and miR\u2212155\u22125p in diabetic nephropathy and the correlation with urinary microalbumin","volume":"20","author":"Bai","year":"2020","journal-title":"Exp Ther Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3233\/NHA-160020","article-title":"MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects","volume":"4","author":"Guglielmi","year":"2017","journal-title":"Nutr Healthy Aging"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150427","article-title":"miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7","volume":"129","author":"McClelland","year":"2015","journal-title":"Clin Science"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2023.0057","article-title":"Clinical value of miR-23a-3p expression in early diagnosis of diabetic kidney disease","author":"Meng","year":"2023","journal-title":"Endokrynol Pol"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-01909","article-title":"Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNF\u03b1-Induced Insulin Resistance","volume":"103","author":"Lozano-Bartolom\u00e9","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3390\/biomedicines12112608","article-title":"Alterations in the levels of urinary exosomal microRNA-183-5p and microRNA-125a-5p in individuals with type 2 diabetes mellitus","volume":"12","author":"Fang","year":"2024","journal-title":"Biomedicines"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS: A J Integr Biol"},{"key":"B64","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3.0: deciphering microRNA function with experimental support","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/diabetology6050035","article-title":"Macrophage dysfunction in tuberculosis\u2013diabetes mellitus comorbidity: A scoping review of immune dysregulation and disease progression","volume":"6","author":"Barry","year":"2025","journal-title":"Diabetology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"30474","DOI":"10.1038\/s41598-025-16385-8","article-title":"Metabolic dysfunction impairs Mycobacterium tuberculosis-specific cytokine and chemokine responses in latent tuberculosis and type 2 diabetes mellitus","volume":"15","author":"Ssekamatte","year":"2025","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1038\/s41598-023-34847-9","article-title":"A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction","volume":"13","author":"Queiroz","year":"2023","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"104173","DOI":"10.1016\/j.ebiom.2022.104173","article-title":"Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment","volume":"82","author":"Van Doorn","year":"2022","journal-title":"eBioMedicine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"108662","DOI":"10.1016\/j.isci.2023.108662","article-title":"The sound of silent RNA in tuberculosis and the lncRNA role on infection","volume":"27","author":"Rocha","year":"2024","journal-title":"iScience"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7424","article-title":"Bioinformatics analysis of microRNA expression between patients with and without latent tuberculosis infections","author":"Lu","year":"2019","journal-title":"Exp Ther Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/cells9102160","article-title":"Tuberculosis-associated microRNAs: from pathogenesis to disease biomarkers","volume":"9","author":"Sinigaglia","year":"2020","journal-title":"Cells"},{"key":"B72","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tube.2013.08.004","article-title":"The roles of microRNAs on tuberculosis infection: Meaning or myth","volume":"93","author":"Harapan","year":"2013","journal-title":"Tuberculosis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"114672","DOI":"10.1016\/j.biopha.2023.114672","article-title":"Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research","volume":"162","author":"Ma","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.10.014","article-title":"MicroRNA-29a-3p reduces TNF\u03b1-induced endothelial dysfunction by targeting tumor necrosis factor receptor 1","volume":"18","author":"Deng","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.21705\/mcbs.v8i1.405","article-title":"The role of hypoxia-inducible factor in mycobacterium tuberculosis-infected macrophages","volume":"8","author":"Fitriana","year":"2024","journal-title":"Mol Cell BioMed Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.727508","article-title":"Extracellular matrix-induced GM-CSF and hypoxia promote immune control of mycobacterium tuberculosis in human in vitro granulomas","volume":"12","author":"Arbu\u00e9s","year":"2021","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0534-0","article-title":"Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration","volume":"38","author":"Qualls","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6837745","DOI":"10.1155\/2022\/6837745","article-title":"Cellular immunity of patients with tuberculosis combined with diabetes","volume":"2022","author":"Cheng","year":"2022","journal-title":"J Immunol Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","author":"Kumar Nathella","year":"2017","journal-title":"Immunology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.919223","article-title":"Respiratory tract infections in diabetes \u2013 lessons from tuberculosis and influenza to guide understanding of COVID-19 severity","volume":"13","author":"Al-Sayyar","year":"2022","journal-title":"Front Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"20230138","DOI":"10.1002\/EXP.20230138","article-title":"Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective","volume":"4","author":"Ye","year":"2024","journal-title":"Exploration"},{"key":"B82","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.jctube.2022.100343","article-title":"Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries","volume":"29","author":"Abbas","year":"2022","journal-title":"J Clin Tuberculosis Other Mycobacterial Diseases"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01086-22","article-title":"High glucose and carbonyl stress impair HIF-1-regulated responses and the control of mycobacterium tuberculosis in macrophages","volume":"13","author":"Ter\u00e1n","year":"2022","journal-title":"mBio"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1013033","article-title":"Distinguishing multiple roles of T cell and macrophage involvement in determining lymph node fates during Mycobacterium tuberculosis infection","volume":"21","author":"Krupinsky","year":"2025","journal-title":"Smith AM editor. PloS Comput Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15282","article-title":"Prevalence of adrenal insufficiency and adrenal morphology in treatment-na\u00efve tuberculosis patients: A cross-sectional study from a high-burden region","volume":"103","author":"Thulaseedharan","year":"2025","journal-title":"Clin Endocrinology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1038\/srep15214","article-title":"Expression profiling of lymph nodes in tuberculosis patients reveal inflammatory milieu at site of infection","volume":"5","author":"Maji","year":"2015","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.669394","article-title":"Genetics and functional mechanisms of STAT3 polymorphisms in human tuberculosis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-019-1533-1","article-title":"STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes","volume":"16","author":"Chen","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15954","article-title":"Phosphorylated STAT3 suppresses microRNA-19b\/1281 to aggravate lung injury in mice with type 2 diabetes mellitus-associated pulmonary tuberculosis","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Medi"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.09.632095","article-title":"c-Myc inhibits macrophage antimycobacterial response in Mycobacterium tuberculosis infection","author":"Sarti","year":"2025","journal-title":"Immunology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1164\/rccm.202112-2747OC","article-title":"Response to hypoxia and the ensuing dysregulation of inflammation impacts mycobacterium tuberculosis pathogenicity","volume":"206","author":"Buc\u015fan","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/biomedicines10040817","article-title":"Restricted activation of the NF-\u03baB pathway in individuals with latent tuberculosis infection after HIF-1\u03b1 Blockade","volume":"10","author":"De Oliveira Rezende","year":"2022","journal-title":"Biomedicines"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600266","article-title":"HIF-1\u03b1 Is an essential mediator of IFN-\u03b3\u2013dependent immunity to mycobacterium tuberculosis","volume":"197","author":"Braverman","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.05.005","article-title":"HIF-1\u03b1 as a central mediator of cellular resistance to intracellular pathogens","volume":"60","author":"Knight","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17167","article-title":"Hypoxia inducible factor-1\u03b1 is an important regulator of macrophage biology","volume":"9","author":"Qiu","year":"2023","journal-title":"Heliyon"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxz048","article-title":"Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection","volume":"31","author":"Osada-Oka","year":"2019","journal-title":"Int Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207402","article-title":"Hypoxia and tissue destruction in pulmonary TB","volume":"71","author":"Belton","year":"2016","journal-title":"Thorax"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2016.06.018","article-title":"Inhibition of apoptosis by Rv2456c through Nuclear factor-\u03baB extends the survival of Mycobacterium tuberculosis","volume":"5","author":"Jurcic Smith","year":"2016","journal-title":"Int J Mycobacteriology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"116082","DOI":"10.1016\/j.diagmicrobio.2023.116082","article-title":"microRNA as biomarkers in tuberculosis: a new emerging molecular diagnostic solution","volume":"108","author":"Agrawal","year":"2024","journal-title":"Diagn Microbiol Infect Disease"},{"key":"B100","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ncrna.2021.12.005","article-title":"Micro RNAs as potential biomarkers in tuberculosis: A systematic review","volume":"7","author":"Pattnaik","year":"2022","journal-title":"Noncoding RNA Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12879-024-09232-0","article-title":"A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis","volume":"24","author":"Gunasekaran","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.18782\/2320-7051.7726","article-title":"Expression and regulation of microRNAs in tuberculosis: A review","volume":"7","author":"Kulshrestha","year":"2019","journal-title":"Int J Pure App Biosci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10020-021-00296-1","article-title":"The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection","volume":"27","author":"Mirzaei","year":"2021","journal-title":"Mol Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"100290","DOI":"10.1016\/j.clinsp.2023.100290","article-title":"Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis","volume":"78","author":"Li","year":"2023","journal-title":"Clinics"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1418085","article-title":"Single molecule measurements of microRNAs in the serum of patients with pulmonary tuberculosis","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2020.44029.10324","article-title":"MicroRNA-155 from sputum as noninvasive biomarker for diagnosis of active pulmonary tuberculosis","volume":"23","author":"Hua","year":"2020","journal-title":"Iranian J Basic Med Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1384510","article-title":"miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis","volume":"12","author":"He","year":"2024","journal-title":"Front Public Health"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/761617","article-title":"Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals","volume":"2013","author":"Zhang","year":"2013","journal-title":"BioMed Res Int"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251697","article-title":"Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study","volume":"16","author":"Zeinali","year":"2021","journal-title":"Rom S editor. PloS One"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05809-z","article-title":"MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling","volume":"66","author":"Zhu","year":"2023","journal-title":"Diabetologia"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3390\/jcm9072184","article-title":"Circulating miRNAs as a predictive biomarker of the progression from prediabetes to diabetes: outcomes of a 5-year prospective observational study","volume":"9","author":"Sidorkiewicz","year":"2020","journal-title":"JCM"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0194-y","article-title":"A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study","volume":"50","author":"Jim\u00e9nez-Lucena","year":"2018","journal-title":"Exp Mol Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.05.002","article-title":"Circulating miRNAs as predictive biomarkers of type 2 diabetes mellitus development in coronary heart disease patients from the CORDIOPREV study","volume":"12","author":"Jim\u00e9nez-Lucena","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"B114","doi-asserted-by":"publisher","first-page":"14274","DOI":"10.1038\/s41598-018-32274-9","article-title":"Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus","volume":"8","author":"Jaeger","year":"2018","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02462","article-title":"MiR-155 regulates PAD4-dependent formation of neutrophil extracellular traps","volume":"10","author":"Hawez","year":"2019","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41419-024-06892-3","article-title":"Neutrophil extracellular traps characterize caseating granulomas","volume":"15","author":"Zlatar","year":"2024","journal-title":"Cell Death Dis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.5588\/pha.13.0024","article-title":"Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review","volume":"3","author":"Harries","year":"2013","journal-title":"Public Health Action"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.04.155","article-title":"Defining a research agenda to address the converging epidemics of tuberculosis and diabetes","volume":"152","author":"Critchley","year":"2017","journal-title":"Chest"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0069","article-title":"Diabetes mellitus and tuberculosis: programmatic management issues","volume":"19","author":"Harries","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2010.02523.x","article-title":"Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis: Research to reduce the joint burden of diabetes and tuberculosis","volume":"15","author":"Harries","year":"2010","journal-title":"Trop Med Int Health"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1305325","article-title":"Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1125946","article-title":"A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis","volume":"13","author":"Liang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0066-5","article-title":"Identification of potential urine proteins and microRNA biomarkers for the diagnosis of pulmonary tuberculosis patients","volume":"7","author":"Wang","year":"2018","journal-title":"Emerging Microbes Infections"},{"key":"B124","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v15.i1.97460","article-title":"Diagnostic utility of microRNA profiles in cavitatory and non-cavitatory pulmonary tuberculosis: Research protocol","volume":"15","author":"Moorthy","year":"2025","journal-title":"World J Exp Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40348-014-0008-9","article-title":"Are microRNAs suitable biomarkers of immunity to tuberculosis","volume":"1","author":"Ueberberg","year":"2014","journal-title":"Mol Cell Pediatr"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12535","article-title":"Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients","volume":"19","author":"Barry","year":"2015","journal-title":"J Cell Mol Medi"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02625-21","article-title":"The association between circulating microRNAs and the risk of active disease development from latent tuberculosis infection: a nested case-control study","volume":"10","author":"Xin","year":"2022","journal-title":"Zhang L editor. Microbiol Spectr"},{"key":"B128","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1183\/13993003.00424-2016","article-title":"Digital health for the End TB Strategy: developing priority products and making them work","volume":"48","author":"Falzon","year":"2016","journal-title":"Eur Respir J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1760933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:27:44Z","timestamp":1771824464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1760933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":128,"alternative-id":["10.3389\/fendo.2026.1760933"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1760933","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1760933"}}